Purpose: To determine intraoperative changes in corneal thickness and outcomes of corneal collagen crosslinking (CXL) using 2 intraoperative regimens: riboflavin-dextran or hypotonic riboflavin.
Setting: Cornea and refractive surgery practice, Teaneck, New Jersey, USA.
Design: Prospective randomized case series.